Atlantic Edge Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
1,291
+81
+7% +$82.8K 0.32% 61
2026
Q1
$1.11M Hold
1,210
0.27% 70
2025
Q4
$1.3M Hold
1,210
0.32% 61
2025
Q3
$923K Buy
1,210
+32
+3% +$23.8K 0.24% 75
2025
Q2
$918K Sell
1,178
-5
-0.4% -$3.88K 0.25% 75
2025
Q1
$977K Sell
1,183
-5
-0.4% -$4.16K 0.3% 72
2024
Q4
$917K Sell
1,188
-56
-5% -$46.4K 0.28% 69
2024
Q3
$1.1M Sell
1,244
-14
-1% -$12.6K 0.34% 69
2024
Q2
$1.14M Sell
1,258
-35
-3% -$28K 0.38% 64
2024
Q1
$1.01M Sell
1,293
-100
-7% -$71.2K 0.35% 68
2023
Q4
$812K Buy
+1,393
New +$813K 0.33% 71

Other funds holding LLY

Atlantic Edge Private Wealth Management's LLY Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $82.8K and bringing the position to 1,291 shares worth $1.55M. The position accounts for 0.32% of the portfolio, ranked #61.

Atlantic Edge Private Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,874 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 1,291 shares of Eli Lilly worth $1.55M as of Q2 2026.
  • Atlantic Edge Private Wealth Management bought 81 Eli Lilly shares in Q2 2026, an estimated $82.8K.
  • Eli Lilly made up 0.32% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,874 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.